The Cre/loxP system, a widely utilized genetic tool that enables precise control over gene expression in specific tissues or at designated times,66 enabled us to specifically target and express the mutant MYOC gene in the TM, the primary disease site in MYOC-associated glaucoma. The gene discussed is MYOC; the disease is glaucoma.